Skip to main content
Article

Pharmacogenetic testing and antidepressants: A clinical perspective

Journal of Affective Disorders
DOI: 10.1016/j.jad.2021.07.071
0Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.
Get full text

References Powered by Scopus

Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation

Pharmacology and Therapeutics
3105Citations
N/AReaders
Get full text

The human cytochrome P450 (CYP) allele nomenclature website: A peer-reviewed database of CYP variants and their associated effects

Human Genomics
174Citations
N/AReaders
Get full text

Does pharmacogenomic testing improve clinical outcomes for major depressive disorder?: A systematic review of clinical trials and cost-effectiveness studies

Journal of Clinical Psychiatry
117Citations
N/AReaders
Get full text
View more at Scopus

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Jagadheesan, K., & Tipirneni, S. (2021, November 1). Pharmacogenetic testing and antidepressants: A clinical perspective. Journal of Affective Disorders. Elsevier B.V. https://doi.org/10.1016/j.jad.2021.07.071

Readers over time

‘21‘22‘24‘2505101520

Readers' Seniority

Tooltip

Lecturer / Post doc 1

100%

Readers' Discipline

Tooltip

Pharmacology, Toxicology and Pharmaceut... 1

100%

Save time finding and organizing research with Mendeley

Sign up for free
0